Woodstock Continues to Hold Position in Bristol (BMY); Cornerstone Investment Partners Has Increased Its Position in Accenture Plc (ACN) by $41.28 Million as Stock Price Declined

Accenture plc (NYSE:ACN) Logo

Woodstock Corp increased its stake in Bristol (BMY) by 18.41% based on its latest 2018Q1 regulatory filing with the SEC. Woodstock Corp bought 7,880 shares as the company’s stock declined 23.11% with the market. The institutional investor held 50,680 shares of the major pharmaceuticals company at the end of 2018Q1, valued at $3.21M, up from 42,800 at the end of the previous reported quarter. Woodstock Corp who had been investing in Bristol for a number of months, seems to be bullish on the $86.69 billion market cap company. The stock increased 1.43% or $0.75 during the last trading session, reaching $53.02. About 6.46 million shares traded. Bristol-Myers Squibb Company (NYSE:BMY) has declined 2.98% since May 31, 2017 and is downtrending. It has underperformed by 15.55% the S&P500.

Cornerstone Investment Partners Llc increased its stake in Accenture Plc (ACN) by 1628.88% based on its latest 2018Q1 regulatory filing with the SEC. Cornerstone Investment Partners Llc bought 269,775 shares as the company’s stock declined 5.31% with the market. The institutional investor held 286,337 shares of the business services company at the end of 2018Q1, valued at $43.95 million, up from 16,562 at the end of the previous reported quarter. Cornerstone Investment Partners Llc who had been investing in Accenture Plc for a number of months, seems to be bullish on the $100.34 billion market cap company. The stock increased 1.62% or $2.49 during the last trading session, reaching $156.03. About 1.58M shares traded. Accenture plc (NYSE:ACN) has risen 26.72% since May 31, 2017 and is uptrending. It has outperformed by 14.15% the S&P500.

More notable recent Bristol-Myers Squibb Company (NYSE:BMY) news were published by: Seekingalpha.com which released: “Bristol-Myers Squibb Is One Stock That You Should Not Ignore” on May 27, 2018, also Seekingalpha.com with their article: “Bristol-Myers Squibb (BMY) Presents at UBS Global Healthcare Conference (Transcript)” published on May 22, 2018, Bizjournals.com published: “Why Big Pharma is finally discovering the Bay Area” on May 23, 2018. More interesting news about Bristol-Myers Squibb Company (NYSE:BMY) were released by: Fool.com and their article: “Why Bristol-Myers Squibb Stock Crashed in April” published on May 09, 2018 as well as Fool.com‘s news article titled: “Read This Before You Buy Immuno-Oncology Stocks” with publication date: May 31, 2018.

Investors sentiment decreased to 0.83 in 2018 Q1. Its down 0.11, from 0.94 in 2017Q4. It turned negative, as 64 investors sold BMY shares while 573 reduced holdings. 111 funds opened positions while 418 raised stakes. 1.12 billion shares or 1.08% more from 1.11 billion shares in 2017Q4 were reported. Gideon Capital holds 0.27% or 6,999 shares in its portfolio. Capwealth Ltd Llc reported 2.12% stake. Smith Salley Assocs reported 0.1% in Bristol-Myers Squibb Company (NYSE:BMY). Whittier Trust Of Nevada Inc invested in 0.71% or 138,226 shares. Mirador Capital Partners Limited Partnership holds 1.28% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY) for 35,082 shares. Washington Tru Co owns 0.07% invested in Bristol-Myers Squibb Company (NYSE:BMY) for 18,090 shares. Riverbridge Partners Ltd accumulated 5,825 shares or 0.01% of the stock. 22,464 were reported by Hancock Holding. Gradient Investments Limited Com owns 8,549 shares. Country Club Trust Co Na holds 0.2% or 25,339 shares in its portfolio. Muhlenkamp holds 178,436 shares. Asset Advisors has invested 0.04% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Verition Fund Mngmt Llc holds 0.06% in Bristol-Myers Squibb Company (NYSE:BMY) or 12,371 shares. Rice Hall James Associate reported 4,608 shares or 0.01% of all its holdings. First Quadrant Ltd Partnership Ca reported 18,663 shares.

Woodstock Corp, which manages about $699.55M and $528.86 million US Long portfolio, decreased its stake in Hanesbrands Inc (NYSE:HBI) by 17,994 shares to 294,733 shares, valued at $5.43 million in 2018Q1, according to the filing. It also reduced its holding in Home Depot Inc (NYSE:HD) by 1,850 shares in the quarter, leaving it with 71,014 shares, and cut its stake in Boeing Co (NYSE:BA).

Among 22 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 6 have Buy rating, 2 Sell and 14 Hold. Therefore 27% are positive. Bristol-Myers Squibb Company had 87 analyst reports since July 28, 2015 according to SRatingsIntel. The firm has “Buy” rating by Citigroup given on Friday, February 16. Cowen & Co maintained it with “Hold” rating and $6500 target in Monday, July 10 report. The stock has “Buy” rating by Guggenheim on Wednesday, December 2. The firm has “Buy” rating given on Monday, December 19 by Jefferies. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned “Hold” rating by Jefferies on Thursday, July 14. The rating was maintained by Citigroup with “Buy” on Wednesday, October 18. UBS maintained Bristol-Myers Squibb Company (NYSE:BMY) on Friday, October 6 with “Buy” rating. Bank of America maintained the shares of BMY in report on Monday, March 5 with “Neutral” rating. The stock has “Hold” rating by Deutsche Bank on Monday, July 17. The stock of Bristol-Myers Squibb Company (NYSE:BMY) has “Sell” rating given on Wednesday, August 16 by BMO Capital Markets.

Since December 12, 2017, it had 2 insider purchases, and 1 insider sale for $163,963 activity. Paliwal Dinesh C bought $249,948 worth of stock or 4,770 shares. Lynch Thomas J. Jr. sold $335,172 worth of Bristol-Myers Squibb Company (NYSE:BMY) on Tuesday, December 12.

Among 26 analysts covering Accenture Plc (NYSE:ACN), 15 have Buy rating, 1 Sell and 10 Hold. Therefore 58% are positive. Accenture Plc had 97 analyst reports since August 12, 2015 according to SRatingsIntel. The stock has “Hold” rating by Susquehanna on Tuesday, December 26. The firm has “Buy” rating given on Friday, October 16 by Cantor Fitzgerald. The firm has “Buy” rating given on Wednesday, September 20 by KeyBanc Capital Markets. The rating was maintained by Pivotal Research with “Buy” on Friday, December 22. The rating was maintained by Cowen & Co with “Buy” on Friday, December 22. The firm has “Buy” rating given on Monday, April 2 by Wedbush. KeyBanc Capital Markets maintained the shares of ACN in report on Thursday, September 28 with “Buy” rating. Citigroup maintained it with “Neutral” rating and $116 target in Wednesday, September 28 report. The stock of Accenture plc (NYSE:ACN) has “Buy” rating given on Thursday, January 11 by Cowen & Co. Wedbush initiated it with “Outperform” rating and $125 target in Friday, September 9 report.

Cornerstone Investment Partners Llc, which manages about $8.61 billion and $2.29 billion US Long portfolio, decreased its stake in Abbvie Inc. (NYSE:ABBV) by 14,830 shares to 16,640 shares, valued at $1.58 million in 2018Q1, according to the filing. It also reduced its holding in Sanofi Ads (NYSE:SNY) by 10,900 shares in the quarter, leaving it with 10,900 shares, and cut its stake in Chevron Corp (NYSE:CVX).

Investors sentiment increased to 0.97 in Q1 2018. Its up 0.04, from 0.93 in 2017Q4. It improved, as 50 investors sold ACN shares while 396 reduced holdings. 105 funds opened positions while 326 raised stakes. 449.75 million shares or 1.56% less from 456.89 million shares in 2017Q4 were reported. First Natl reported 0.15% in Accenture plc (NYSE:ACN). Suntrust Banks Inc stated it has 123,901 shares. Bnp Paribas Arbitrage holds 0% of its portfolio in Accenture plc (NYSE:ACN) for 206,975 shares. Bartlett And Limited holds 1.17% or 184,168 shares. Wealthfront invested in 0.04% or 25,597 shares. Eagle Ridge Inv invested in 3,482 shares or 0.08% of the stock. Moreover, Morgan Stanley has 0.49% invested in Accenture plc (NYSE:ACN). Delta Asset Management Ltd Liability Corporation Tn owns 107 shares for 0% of their portfolio. Shellback Cap Limited Partnership accumulated 75,000 shares or 0.84% of the stock. Bb&T reported 245,742 shares stake. Martingale Asset Mgmt Limited Partnership holds 0.72% of its portfolio in Accenture plc (NYSE:ACN) for 366,544 shares. South Dakota Investment Council invested in 18,400 shares. Webster Natl Bank N A invested 0.05% in Accenture plc (NYSE:ACN). Moreover, Weiss Multi has 0.24% invested in Accenture plc (NYSE:ACN). Stonebridge Capital Advsr Limited Liability Com accumulated 4,438 shares.

More recent Accenture plc (NYSE:ACN) news were published by: Streetinsider.com which released: “Accenture (ACN) Announces Acquisition of HO Communication” on May 23, 2018. Also Businesswire.com published the news titled: “Pinnacle Awards Based on Outstanding Contributions and Dedication to Teamwork” on May 29, 2018. Seekingalpha.com‘s news article titled: “Buy Accenture” with publication date: May 07, 2018 was also an interesting one.

Bristol-Myers Squibb Company (NYSE:BMY) Institutional Positions Chart